A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes

AIMS/HYPOTHESIS: This 52-week multinational, randomised, open-label, parallel-group, non-inferiority trial compared clinical outcomes following supplementation of oral glucose-lowering drugs with basal insulin analogues detemir and glargine in type 2 diabetic patients. METHODS: Insulin-naive adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenstock, J., Davies, M., Home, P. D., Larsen, J., Koenen, C., Schernthaner, G.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2008
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235909/
https://www.ncbi.nlm.nih.gov/pubmed/18204830
http://dx.doi.org/10.1007/s00125-007-0911-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2235909/
https://www.ncbi.nlm.nih.gov/pubmed/18204830
http://dx.doi.org/10.1007/s00125-007-0911-x

Ejemplares similares